INNATE PHARMA SA (IPH.PA)

FR0010331421 - Common Stock

2.2  +0.01 (+0.46%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
43.65M49.58M12.11M56.16M68.97M
Cost Of Goods
3.14M3.58M3.06M3.59M3.21M
Gross Profit
40.51M46.00M9.05M52.56M65.77M
Operating Expenses
65.83M62.42M56.87M51.49M92.82M
Research and Development
53.06M45.46M41.21M37.74M59.97M
Selling, General, and Administrative Expenses
17.66M20.24M23.35M17.54M23.95M
Operating Income
-25.32M-16.42M-47.83M1.08M-27.05M
Interest Income/Expense
2.02M1.09M1.26M-1.36M2.21M
Other Income/Expense
1.67M-1.63M1.08M-552.00K4.08M
Non Recurring Items
N/A-41.00MN/A-43.53MN/A
Income Before Taxes
-62.63M-57.97M-45.48M-829.00K-20.76M
Income Tax
0.000.000.000.000.00
Net Income
-62.69M-58.10M-52.81M-63.98M-20.76M
EBITDA
21.70M28.98M-43.23M57.88M-10.52M
 
Per Share Data
EPS Diluted Total Ops
-0.79-0.73-0.66-0.81-0.31
 
Statistics
Gross Profit Margin
92.80%92.78%74.69%93.61%95.35%
Profit Margin
-143.61%-117.19%-436.01%-113.94%-30.10%
Operating Profit Margin
-58.00%-33.13%-394.86%1.92%-39.22%

All data in EUR

Charts